All In Biotech

NDA 020832 · Becton Dickinson CO

Chloraprep One-Step

Chlorhexidine Gluconate, Isopropyl Alcohol · Topical

Last checked: Nov 20, 2026Latest source record: Apr 3, 2019 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations

First approved

2000

Jul 14, 2000

Approved uses

1

Original approval plus efficacy supplements

Registered trials

551

112 Phase 3, 30 recruiting

FAERS reports

297

272 serious, 28 with death reported

AI brief across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.

What it is approved for

From the label in effect Oct 23, 2026.

Use for the preparation of the patient’s skin prior to surgery. Helps to reduce bacteria that potentially can cause skin infection.

Approval history

Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.

  • Jul 14, 2000 Original approval · Type 4 - New Combination ReviewLetter
8 products under this application
  • CHLORAPREP ONE-STEP · CHLORHEXIDINE GLUCONATE 2%; ISOPROPYL ALCOHOL 70% (1ML) · SPONGE, TOPICAL · Over-the-counter
  • CHLORAPREP ONE-STEP · CHLORHEXIDINE GLUCONATE 2%; ISOPROPYL ALCOHOL 70% (26ML) · SPONGE, TOPICAL · Over-the-counter
  • CHLORAPREP ONE-STEP · CHLORHEXIDINE GLUCONATE 2%; ISOPROPYL ALCOHOL 70% (10.5ML) · SPONGE, TOPICAL · Over-the-counter
  • CHLORAPREP WITH TINT · CHLORHEXIDINE GLUCONATE 2%; ISOPROPYL ALCOHOL 70% (26ML) · SPONGE, TOPICAL · Over-the-counter
  • CHLORAPREP WITH TINT · CHLORHEXIDINE GLUCONATE 2%; ISOPROPYL ALCOHOL 70% (3ML) · SPONGE, TOPICAL · Over-the-counter
  • CHLORAPREP WITH TINT · CHLORHEXIDINE GLUCONATE 2%; ISOPROPYL ALCOHOL 70% (10.5ML) · SPONGE, TOPICAL · Over-the-counter
  • CHLORAPREP ONE-STEP FREPP · CHLORHEXIDINE GLUCONATE 2%; ISOPROPYL ALCOHOL 70% (1.5ML) · SPONGE, TOPICAL · Over-the-counter
  • CHLORAPREP ONE-STEP · CHLORHEXIDINE GLUCONATE 2%; ISOPROPYL ALCOHOL 70% (3ML) · SPONGE, TOPICAL · Over-the-counter

Clinical trials

Interventional ClinicalTrials.gov studies with "Chlorhexidine Gluconate" as an intervention, any sponsor and status, largest first.

All 551 trials

Most reported adverse reactions

FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.

Signals
  • sinusitis211
  • pain206
  • lower respiratory tract infection205
  • pruritus192
  • rash187
  • joint swelling186
  • peripheral swelling180
  • insomnia179
  • impaired healing156
  • weight increased156
  • stomatitis155
  • folliculitis154

FAERS reports by year

By the date FDA received the report.

View as table
YearReports
20062
20071
20092
20105
20111
20121
201520
20167
20173
20182
201916
202021
202171
202276
202329
202433
20254
20263

Recalls

25 FDA enforcement reports for this application.

  • Jul 9, 2026 · Class II · Ongoing

    Lack of Assurance of Sterility: Affected product may exhibit an open or incomplete seal on the packaging of the applicator

  • Jun 11, 2026 · Class II · Ongoing

    Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel

  • Jun 11, 2026 · Class II · Ongoing

    Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel

  • Jun 11, 2026 · Class II · Ongoing

    Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel

  • Jun 11, 2026 · Class II · Ongoing

    Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel

  • Jun 11, 2026 · Class II · Ongoing

    Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel

  • Jun 11, 2026 · Class II · Ongoing

    Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel

  • Jun 11, 2026 · Class II · Ongoing

    Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel

Shortages

FDA's drug shortage list.

Not on FDA's shortage list.

Medicare spending

CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.

Compare

Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.

Published evidence

PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.

All 571 on PubMed

Sponsor: Becton Dickinson CO · Also marketed as Chloraprep With Tint, Chloraprep One-Step Frepp

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.